BACKGROUND Polycystic ovary syndrome(PCOS)is a common disorder in women of reproductive age.Over the last few decades,research studies have revealed that PCOS is strongly associated with metabolic disorders,including ...BACKGROUND Polycystic ovary syndrome(PCOS)is a common disorder in women of reproductive age.Over the last few decades,research studies have revealed that PCOS is strongly associated with metabolic disorders,including metabolic syndrome,obesity,insulin resistance and prediabetes.Clinical observation has shown that women with PCOS are expected to have an increased risk of developing type 2 diabetes(T2DM)in the future.AIM To assess the hazard ratio(HR)of T2DM between women with/without PCOS.METHODS This population-based,retrospective cohort study evaluated data retrieved from the National Health Insurance Research Database.The subjects were women with PCOS(n=2545)identified on the basis of diagnosis,testing,or treatment codes,and women without PCOS as controls(n=2545).The HR of T2DM between women with or without PCOS was the main outcome measure analyzed.RESULTS Our study found that, during a 10-year follow-up period, the overall incidence of T2DM was 6.25per 1000 person-years in the PCOS group compared with 1.49 in the control group. Afteradjustment for potential confounding variables, the overall incidence of T2DM was higher in thePCOS group vs the control group (HR = 5.13, 95%CI: 3.51-7.48, P < 0.0001). The risk of developingT2DM subsequent to PCOS decreased with increasing diagnosis age: the adjusted HR was 10.4 inthe 18–24-year age group, 5.28 in the 25-29-year age group, and 4.06 in the 29-34-year age group.However, no such significant association was noted in women older than 35 years.CONCLUSIONThese findings highlight the importance of prompting a more aggressive treatment to preventdiabetes in women diagnosed with PCOS at a young age, and, in contrast, the lessened importanceof this type of intervention in women diagnosed with PCOS at a late reproductive age.展开更多
基金Supported by the Show Chwan Memorial Hospital,No. SRD-108014
文摘BACKGROUND Polycystic ovary syndrome(PCOS)is a common disorder in women of reproductive age.Over the last few decades,research studies have revealed that PCOS is strongly associated with metabolic disorders,including metabolic syndrome,obesity,insulin resistance and prediabetes.Clinical observation has shown that women with PCOS are expected to have an increased risk of developing type 2 diabetes(T2DM)in the future.AIM To assess the hazard ratio(HR)of T2DM between women with/without PCOS.METHODS This population-based,retrospective cohort study evaluated data retrieved from the National Health Insurance Research Database.The subjects were women with PCOS(n=2545)identified on the basis of diagnosis,testing,or treatment codes,and women without PCOS as controls(n=2545).The HR of T2DM between women with or without PCOS was the main outcome measure analyzed.RESULTS Our study found that, during a 10-year follow-up period, the overall incidence of T2DM was 6.25per 1000 person-years in the PCOS group compared with 1.49 in the control group. Afteradjustment for potential confounding variables, the overall incidence of T2DM was higher in thePCOS group vs the control group (HR = 5.13, 95%CI: 3.51-7.48, P < 0.0001). The risk of developingT2DM subsequent to PCOS decreased with increasing diagnosis age: the adjusted HR was 10.4 inthe 18–24-year age group, 5.28 in the 25-29-year age group, and 4.06 in the 29-34-year age group.However, no such significant association was noted in women older than 35 years.CONCLUSIONThese findings highlight the importance of prompting a more aggressive treatment to preventdiabetes in women diagnosed with PCOS at a young age, and, in contrast, the lessened importanceof this type of intervention in women diagnosed with PCOS at a late reproductive age.
